Find out now if you qualify. Time is limited to file a claim. You may be entitled to compensation. Fill out the form below to see if you qualify.
Cancer Patients At Risk
Information submitted will be transmitted to a law firm. This communication is intended to be an attorney-client communication for purposes of evaluating your claim and will be kept confidential by the law firm. The communication does not create an attorney-client relationship and no relationship is formed until a fee agreement is signed by you and the law firm. I also have read and agree to your Privacy Policy
File Your Claim Now
April 2022: The MDL Paraquat class action judge will have a status conference on April 1st to review where the litigation is headed and how best to take the bellwether lawsuits forward for trial in November 2022. 44 new paraquat lawsuits have been added to the MDL in the last two weeks. At this pace, April 2022 will be the busiest month for new files yet. Last week, the parties filed their class-action bellwether picks with the Paraquat MDL judge. Those choices, however, have not been made public.
May 2022: In the last month, over 50 new cases have been added to the Paraquat Lawsuit Multidistrict Litigation (MDL). A group of six patients was recently selected by the Paraquat MDL court for the initial Paraquat Parkinson's disease bellwether trials. As a result, the first trial in November 2022 is approaching soon. The strategy is to select 16 paraquat claims from among the almost 1000 Parkinson's disease litigation claims filed. Following some limited fact discovery in these instances, paraquat attorneys on both sides submitted a preference list to the MDL court, ranking the 16 cases in order of priority. Attorneys for plaintiffs seek the finest facts for their clients, while defense attorneys want the worst. The judge whittled the list down to six Paraquat claims based on these rankings.
CLAIM UPDATES
We are here to listen and help answer all your questions. Contact us today for a Free Claim Review by filling out the form above.
How We Can Help
If you or a family member suffered from adverse effects after taking Keytruda, our experienced legal team will handle every aspect of the process, including gathering medical records and expert evaluations. Every state has strict statutes of limitations and special wrongful-death deadlines. If Keytruda-related injury or death occurred, contact us promptly so we can preserve records and protect your rights.
Seek Justice Today
Maryland Juvenile Detention
Abuse Claim Help
Jeff Brandow
Sexual Abuse
Claim Help
File Your Claim Now
If you or a loved one suffered side effects including renal/kidney failure or a fatal complication following Keytruda, you may be eligible to pursue a claim. Our team reviews oncology records, infusion logs, and hospital labs to connect the timeline, preserve evidence, and fight for compensation.
To prove a Keytruda injury case, we first build a precise timeline that maps the onset and progression of symptoms to infusion dates and any dose holds or stops. We then gather causation evidence, including treating-physician notes, cardiology and nephrology consults, trends in troponin, CK, and creatinine, relevant imaging and biopsies, and label-recognized immune-mediated toxicities. We document damages such as ICU stays, dialysis, long-term disability, lost earnings, and wrongful-death losses. Finally, we identify responsible parties—pursuing potential failure-to-warn/product-liability claims and, where appropriate, medical negligence claims (e.g., missed monitoring)—based on the specific facts and applicable state law.
"Trust our experienced team to handle your claim with care and commitment. Contact us today for reliable legal support."
Our dedicated team will fight for your rights and compensation. Confidentiality, Safety, & Justice are our top priorities
How to Qualify for a Depo-Provera Claim:
Use of Depo-Provera
Diagnosis of Brain Tumor
Document Evidence
Submit The Form Above
Depo-Provera is an injectable birth control containing the synthetic hormone medroxyprogesterone acetate, is linked to an increased risk of meningioma, a rare brain tumor. This risk was not adequately disclosed to consumers or medical professionals. Studies, including those published in the Journal of the American Medical Association (JAMA), have shown that long-term use of Depo-Provera significantly raises the risk of developing meningiomas.
Claims against Pfizer, Inc., the drug’s manufacturer, alleges that the company knew or should have known about the increased risk of meningiomas—brain tumors that can cause severe neurological symptoms—especially with prolonged use. The claims state that Pfizer failed to adequately warn doctors and patients, rushed the drug to market without sufficient long-term studies, and prioritized profits over safety.
Due to the rising number of claims against Pfizer regarding Depo-Provera and brain tumors have been consolidated into multidistrict litigation (MDL) in federal court. Affected individuals may seek compensation for medical expenses, long-term care, and other damages, with the potential for federal court consolidation of cases.
Keytruda Claim Help
Justice & Compensation - Start Here
It’s important to work closely with your healthcare provider on your treatment plan, but you should also explore your legal options. Anyone who was prescribed Keytruda and experienced complications, please fill out the form above.
Start by gathering and preserving your records—infusion logs, current medication list, ER and hospital summaries, and lab printouts such as creatinine/eGFR, AST/ALT, troponin, and CK. Then begin a free case review with our team: we’ll confirm eligibility, retrieve the necessary medical records, and explain next steps. You pay no fees unless we recover for you.
Do you qualify?
You may have a claim if any of the following occurred during Keytruda treatment or within the last 4 years:
Kidney/renal failure or biopsy-proven immune-mediated nephritis (e.g., creatinine spike, dialysis, persistent eGFR decline).
Death or life-threatening events tied to myocarditis, cardiomyopathy, myositis, myasthenia gravis, liver failure/hepatitis, or Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN).
What we look for: infusion dates (HCPCS J9271), oncology notes, ER records, troponin/CK trends, creatinine/eGFR, liver panels, EMG/antibody testing for MG, biopsy reports, and death certificates.
Keytruda “releases the brakes” on the immune system. In some people it triggers immune-mediated attacks on healthy organs, which can be severe or fatal and may occur during therapy or after it stops. FDA-recognized events include nephritis (kidney), hepatitis (liver), myocarditis (heart), myositis, myasthenia gravis, and severe skin reactions like SJS/TEN.
